atai Life Sciences to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

atai Life Sciences N.V. (Nasdaq: ATAI) announced its participation in key investor conferences in November 2021 aimed at transforming mental health treatment. Notable events include the Berenberg US CEO Conference on November 9-10, and the Credit Suisse 30th Annual Healthcare Conference on November 11 at 9:40 a.m. ET, featuring a fireside chat format. The 12th Annual Jefferies London Healthcare Conference is set for November 18, also featuring a fireside chat at 8:00 a.m. ET. Archived webcasts will be available on the company's website.

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in the following upcoming investor conferences in November:

Presentation details can be found below:

• Berenberg US CEO Conference 2021
  Format: 1x1 Meetings
  Dates: Tuesday, November 9^th, 2021 – Wednesday, November 10^th, 2021

• Credit Suisse 30th Annual Healthcare Conference
  Format: Fireside Chat
  Date and Time: Thursday, November 11^th, 2021, 9:40 a.m. ET
  Webcast Link: https://kvgo.com/cs-2021-healthcare-conf/atai-life-sciences-nov

• 12^th Annual Jefferies London Healthcare Conference
  Format: Fireside Chat
  Date and Time: Thursday, November 18^th, 2021, 8:00 a.m. ET
  Webcast Link: https://wsw.com/webcast/jeff201/atai/1818738

The presentations and archived webcasts will also be accessible in the Events section of atai’s website.

About atai Life Sciences

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.

atai's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies, seeking to effectively treat and ultimately heal mental health disorders.

atai's mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. atai is headquartered in Berlin, with offices in New York and London. For more information, please visit www.atai.life.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the important factors discussed under the caption “Risk Factors” in atai's prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission (“SEC”) on June 21, 2021, as such factors may be updated from time to time in atai's other filings with the SEC. atai disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.

Contact Information

Investor Contact:
Chad Messer
VP, Investor Relations, atai Life Sciences
Email: chad@atai.life

Media Contact:
Camilla Dormer
VP, Communications, atai Life Sciences
Email: camilla@atai.life

FAQ

What investor conferences will ATAI participate in during November 2021?

ATAI will participate in the Berenberg US CEO Conference on November 9-10, the Credit Suisse 30th Annual Healthcare Conference on November 11 at 9:40 a.m. ET, and the 12th Annual Jefferies London Healthcare Conference on November 18 at 8:00 a.m. ET.

Where can I find the webcast of ATAI's presentations?

The webcast links for ATAI's presentations can be found on the company's events section of their website.

What is the focus of ATAI Life Sciences?

ATAI Life Sciences focuses on developing innovative treatments for mental health disorders, including depression and anxiety, with an emphasis on psychedelic therapy.

What is the format of ATAI's presentations at the conferences?

ATAI's presentations will include 1x1 meetings and fireside chats at the respective conferences.